rs368513342
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 6P and 4B. PM1PM5PP3_ModerateBS2
The NM_000202.8(IDS):c.236C>T(p.Ala79Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000064 in 1,093,191 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A79G) has been classified as Likely benign.
Frequency
Consequence
NM_000202.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IDS | NM_000202.8 | c.236C>T | p.Ala79Val | missense_variant | Exon 2 of 9 | ENST00000340855.11 | NP_000193.1 | |
IDS | NM_001166550.4 | c.10C>T | p.Arg4Cys | missense_variant | Exon 2 of 9 | NP_001160022.1 | ||
IDS | NM_006123.5 | c.236C>T | p.Ala79Val | missense_variant | Exon 2 of 8 | NP_006114.1 | ||
IDS | NR_104128.2 | n.405C>T | non_coding_transcript_exon_variant | Exon 2 of 9 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 exomes AF: 0.0000115 AC: 2AN: 173948Hom.: 0 AF XY: 0.0000168 AC XY: 1AN XY: 59520
GnomAD4 exome AF: 0.00000640 AC: 7AN: 1093191Hom.: 0 Cov.: 29 AF XY: 0.00000836 AC XY: 3AN XY: 358971
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The p.A79V variant (also known as c.236C>T), located in coding exon 2 of the IDS gene, results from a C to T substitution at nucleotide position 236. The alanine at codon 79 is replaced by valine, an amino acid with similar properties. Another alteration at this position has been reported in the literature in an individual with mild symptoms of Hunter syndrome (Karsten S et al. Hum. Genet. 1998 Dec;103(6):732-5). This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Mucopolysaccharidosis, MPS-III-A Uncertain:1
- -
Mucopolysaccharidosis, MPS-II Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at